Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.
about
Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for cliniciansPharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseNo association of a set of candidate genes on haloperidol side effects.Genetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis.Genetic correlates of adult attachment style.D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells.No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia PatientsThe promise and reality of pharmacogenetics in psychiatryClinical implications of pharmacogenomics for tardive dyskinesia.Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in miceWeight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studiesThe G protein-coupled receptors: pharmacogenetics and disease.Review: The biological basis of antipsychotic response in schizophrenia.Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions.DRD2/ANKK1 Taq1A (rs 1800497 C>T) genotypes are associated with susceptibility to second generation antipsychotic-induced akathisia.Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis.Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia.Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors.A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.
P2860
Q24657338-545EE2F9-0964-4869-A1D0-0DA1E9E4B63AQ28252209-52CA164E-9BB7-45DD-AA99-28685F916D8EQ30424511-D428ACDB-BA30-4DCD-9FDE-097705534222Q30445406-019F3ABA-C70E-45F6-8BDB-2A4784114544Q34013256-4F8431B5-BDBA-47EA-B109-F42B4BACB4F4Q34094439-48F7D7EA-C483-4C02-B481-5CFB078FFEA1Q34811987-6932CB89-5605-4EA3-A7A1-4716FD373663Q35226451-EF25B59C-0EDA-424F-97B9-1CF9EC14D50CQ35712215-DB6CE790-23E5-4F19-A198-EE136049B353Q35974641-403BE3E7-B8C6-4493-9C85-D1B3792677C5Q36230583-2A34A5F6-720D-428C-BB1B-046CDE61E8A7Q36310854-127DE7A5-A2E9-456F-8AED-E25E1258792EQ37638930-6AA42E91-D749-45E6-BBB8-AEFF89E3105DQ37791156-E9BC47CB-5DF1-4F5D-880A-12085D26715AQ37952823-22EDE0A6-4E44-4566-98E6-09A7648AE4F7Q40136199-398570E4-7E9F-484C-A1CB-343C8129881AQ44203842-41B66F6A-06DF-4D20-97CB-FD29B41C895CQ44411863-BE7D366A-9087-4FC5-B522-3F0922AD9F6AQ44635660-2E28E29F-AFA0-4DC9-A67C-89214ADBB6C7Q44977105-9768C613-0065-44DD-A8CE-C5D0C4DCAB6FQ45977566-6DE62B31-9674-44F7-BCD5-6FDA0FC4366FQ46422249-65C2AA1D-76F0-4DE3-B171-0DDE1E1EA976Q48006592-682BEFB4-1D4E-423B-936C-DC4D4D919522Q50794479-114B6D74-EDAB-4DBB-BD73-6FE926F98FBF
P2860
Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Relationship between adverse effects of antipsychotic treatment and dopamine D
@nl
Relationship between adverse e ...... n patients with schizophrenia.
@en
type
label
Relationship between adverse effects of antipsychotic treatment and dopamine D
@nl
Relationship between adverse e ...... n patients with schizophrenia.
@en
prefLabel
Relationship between adverse effects of antipsychotic treatment and dopamine D
@nl
Relationship between adverse e ...... n patients with schizophrenia.
@en
P2093
P2860
P356
P1433
P1476
Relationship between adverse e ...... n patients with schizophrenia.
@en
P2093
Brockmöller J
Klufmöller F
Tremblay PB
P2860
P2888
P304
P356
10.1038/SJ.MP.4001054
P407
P577
2002-01-01T00:00:00Z